Medicines Australia expands transparency.
Medicines Australia has just announced the release of the first report of Advisory Board meetings held in the first quarter of 2013, as a significant additional move towards exposure of payments by pharmaceutical companies to health professionals.
Advisory Boards generally consist of doctors and other health workers, but can include consumer representatives, and provide “essential advice to pharmaceutical companies on their product or group of products”.
The Advisory Board reports are part of the new 17th edition of the Medicines Australia Code of Conduct, which MA ceo Brendan Shaw said provides “greater confidence that interactions between healthcare professionals and companies are appropriate”.
Further transparency measures will include reports on payments to healthcare professional consultants and support for health consumer organisations, which are due for release early next year, Shaw added.
The reports can be accessed at www.medicinesaustralia.com.au
More information in today’s Pharmacy Daily.
This Pharmacy Daily breaking news brought to you by Pharmacy Daily.
